Blog
RSS FeedPosted by Michael Wonder on 20 Sep 2024
BioCryst and the pan-Canadian Pharmaceutical Alliance successfully complete negotiations for Orladeyo (berotralstat), an oral, once daily therapy for the prevention of hereditary angioedema attacks
17 September 2024 - BioCryst Pharmaceuticals today announced that it successfully completed negotiations with the pan-Canadian Pharmaceutical Alliance for oral, ...
Posted by Michael Wonder on 20 Sep 2024
Abrysvo: Pfizer Canada's newly publicly funded vaccine a step towards national RSV prevention in older adults
19 September 2024 - Today, Pfizer Canada announced that Abrysvo has been selected as the publicly funded vaccine for the ...
Posted by Michael Wonder on 19 Sep 2024
Program to protect SA newborns from RSV
17 September 2024 - South Australia will protect newborn babies from the impacts of respiratory syncytial virus for the winter ...
Posted by Michael Wonder on 18 Sep 2024
Making more new cancer treatments available for New Zealanders
18 September 2024 - PHARMAC is consulting on a proposal to fund the medicine lenvatinib mesylate for three types of cancer ...
Posted by Michael Wonder on 17 Sep 2024
5,700 people to benefit from widened access to funded medicines
17 September 2024 - PHARMAC is widening access to seven medicines, benefitting an estimated 5,700 people within the first year ...
Posted by Michael Wonder on 13 Sep 2024
UnitedHealth to remove AbbVie's Humira from some US drug reimbursement lists next year
10 September 2024 - UnitedHealth Group said on Tuesday it will remove AbbVie’s blockbuster rheumatoid arthritis drug Humira from some ...
Posted by Michael Wonder on 12 Sep 2024
New medicines could be PBS listed in just four weeks under a proposal the health minister calls 'visionary'
11 September 2024 - Have you ever had to wait for an important and expensive medicine to be subsidised? ...
Posted by Michael Wonder on 12 Sep 2024
Merck Canada and the pan-Canadian Pharmaceutical Alliance successfully complete negotiations for Welireg (belzutifan)
5 September 2024 - Merck announced that it has successfully completed negotiations with the pan-Canadian Pharmaceutical Alliance for Welireg (belzutifan) on ...
Posted by Michael Wonder on 11 Sep 2024
New medicine and an easier renewal process proposed for people with ADHD
12 September 2024 - PHARMAC is asking for feedback on two changes for people with attention deficit hyperactivity disorder - ...
Posted by Michael Wonder on 11 Sep 2024
HTA review outlines First Nations, pediatric reform and quick, cheap medicine
10 September 2024 - A Government review of Australia’s systems for accessing medicine has said it could slash waiting times ...
Posted by Michael Wonder on 09 Sep 2024
First cancer medicine decision following PHARMAC funding boost
9 September 2024 - PHARMAC has decided to widen access to two medicines for several types of cancer. ...
Posted by Michael Wonder on 09 Sep 2024
New and expanded PBS listings for Fabry disease and kidney cancer
9 September 2024 - Australians with Fabry disease, a rare genetic condition, and people with kidney cancer now have access ...
Posted by Michael Wonder on 04 Sep 2024
Lilly Canada and the pan-Canadian Pharmaceutical Alliance successfully complete negotiations for Omvoh (mirikizumab) for adults with moderately to severely active ulcerative colitis
3 September 2024 - Eli Lilly Canada announced today that it successfully completed negotiations with the pan-Canadian Pharmaceutical Alliance for Omvoh ...
Posted by Michael Wonder on 01 Sep 2024
Cabometyx (cabozantinib) now available for eligible patients with non-clear cell renal cell carcinoma via the PBS
1 September 2024 - Cabometyx (cabozantinib), a once daily oral medication, is now available on the PBS for eligible patients with ...
Posted by Michael Wonder on 31 Aug 2024
Schedule of Pharmaceutical Benefits - 1 September 2024
The September 2024 issue of the Schedule of Pharmaceutical Benefits is out and now in effect. ...